The UCLA Tumor Cell Biology Program features training at the doctoral and postdoctoral levels in hypothesis-driven and global screening-oriented research aimed at identifying features/markers of value in diagnosis, prognosis and treatment of cancer. The current trainee group includes fundamental biologists, mathematicians, and informaticists as well as clinical scientists and training activities that promote communication and collaboration between them. Technologies employed by project trainees include characterization of stem cells that are possible progenitors of tumors, global assessment of patient samples for gene expression, proteins and DMA methylation, creation of mouse models designed to recapitulate human cancer, and assessment of cellular features revealed by immunological or other staining methods in tissue microarrays. Trainees participate in a core survey course that presents a broad view of experimental and clinical cancer research, cancer diagnosis, prognosis, therapy and prevention. A new required course on cancer systems biology will focus on genomic, proteomic and epigenetic technologies and methods of analysis for extracting relevant and clinically useful features from large and/or diverse data sets obtained from patient and control populations. Trainees are required to complete a course on ethics and accountability in research, participate in a monthly seminar featuring trainee presentations, and attend the weekly cancer research conference sponsored by the Cancer Center. Trainees have access to a biotechnology course taught jointly in the College and in the Business School that offers an integrated view of business and technology in translational research. Among studies that are relevant to the public health, program scientists have i) employed gene expression analysis to reveal signatures that separate patients responding to a therapy from those who do not and identify signatures that predict a patients susceptibility to small molecular drugs acting on specific signal transduction sites, ii) proteome-wide screening to identify panels of features that may offer earlier and improved diagnosis of prostate cancer, and iii) demonstrated histone-modifications in tissue microarrays that separate prostate cancer patients into groups that are more vs. less susceptible to clinical recurrence.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009056-35
Application #
7860502
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M1))
Program Officer
Lim, Susan E
Project Start
1980-07-01
Project End
2011-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
35
Fiscal Year
2010
Total Cost
$495,680
Indirect Cost
Name
University of California Los Angeles
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Fernando, Thilini R; Contreras, Jorge R; Zampini, Matteo et al. (2017) The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia. Mol Cancer 16:126
Youn, Minyoung; Wang, Nan; LaVasseur, Corinne et al. (2017) Loss of Forkhead box M1 promotes erythropoiesis through increased proliferation of erythroid progenitors. Haematologica 102:826-834
Williams, Carmen J; Chu, Alison; Jefferson, Wendy N et al. (2017) Epithelial membrane protein 2 (EMP2) deficiency alters placental angiogenesis, mimicking features of human placental insufficiency. J Pathol 242:246-259
Wang, Wenyuan; Org, Tonis; Montel-Hagen, Amélie et al. (2016) MEF2C protects bone marrow B-lymphoid progenitors during stress haematopoiesis. Nat Commun 7:12376
Shurell, Elizabeth; Vergara-Lluri, Maria E; Li, Yunfeng et al. (2016) Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma. Oncotarget 7:72860-72867
Su, Xinming; Esser, Alison K; Amend, Sarah R et al. (2016) Antagonizing Integrin ?3 Increases Immunosuppression in Cancer. Cancer Res 76:3484-95
Wu, Ting-Hsiang; Sagullo, Enrico; Case, Dana et al. (2016) Mitochondrial Transfer by Photothermal Nanoblade Restores Metabolite Profile in Mammalian Cells. Cell Metab 23:921-9
Lee, John K; Phillips, John W; Smith, Bryan A et al. (2016) N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. Cancer Cell 29:536-547
Ruscetti, M; Dadashian, E L; Guo, W et al. (2016) HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer. Oncogene 35:3781-95
Gujar, Amit D; Le, Son; Mao, Diane D et al. (2016) An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc Natl Acad Sci U S A 113:E8247-E8256

Showing the most recent 10 out of 164 publications